The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia.
Venetoclax (VEN, ABT-199/GDC-0199) is an orally bioavailable BH3-mimetic that specifically inhibits the anti-apoptotic B-cell lymphoma/leukemia 2 (BCL2) protein. Although BCL2 overexpression is not genetically driven in chronic lymphocytic leukemia (CLL), it is nearly universal and represents a highly important and prevalent mechanism of apoptosis evasion, making it an attractive therapeutic target. This review summarizes the role of BCL2 in CLL pathogenesis, the development path targeting its inhibition prior to VEN, and the preclinical and clinical data regarding the effectiveness and safety of VEN. We further strive to contextualize VEN in the current CLL treatment landscape and discuss potential mechanisms of resistance.
Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Gilad
G
Itchaki
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Jennifer R
JR
Brown
ABT-199; B-cell chronic lymphocytic leukemia; venetoclax
Lancet Oncol. 2010 Dec;11(12):1149-59
21094089
Blood. 2008 Nov 1;112(9):3807-17
18599795
Br J Cancer. 2007 Sep 17;97(6):769-77
17726463
Haematologica. 2015 Aug;100(8):e302-6
25957396
Oncotarget. 2015 Jul 10;6(19):16912-25
26219338
Blood. 2009 Apr 30;113(18):4403-13
19008458
N Engl J Med. 2014 Mar 20;370(12):1101-10
24401022
Semin Hematol. 2014 Jul;51(3):219-27
25048785
Blood Cancer J. 2015 Nov 13;5:e368
26565405
Cancer Discov. 2014 Mar;4(3):362-75
24346116
Blood. 2015 Jul 23;126(4):471-7
26065659
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11636-41
26324892
Lancet. 2010 Oct 2;376(9747):1164-74
20888994
N Engl J Med. 2016 Jan 28;374(4):311-22
26639348
Blood. 2009 Jan 15;113(3):535-7
19008456
Semin Cancer Biol. 2010 Dec;20(6):370-6
20863894
Am J Cancer Res. 2015 Jul 15;5(8):2361-75
26396912
Blood. 2016 Jan 14;127(2):208-15
26486789
Blood. 2016 Jan 21;127(3):303-9
26492934
Cancer Cell. 2006 Nov;10(5):389-99
17097561
Nat Med. 2013 Feb;19(2):202-8
23291630
J Clin Oncol. 2013 Jan 1;31(1):88-94
23045577
Blood. 2016 Jul 14;128(2):195-203
27247136
N Engl J Med. 2015 Dec 17;373(25):2425-37
26639149
Exp Hematol. 2016 Jan;44(1):38-49.e1
26325331
Clin Cancer Res. 2010 Aug 15;16(16):4217-25
20601444
Am J Hematol. 2015 May;90(5):446-60
25908509
Blood. 1993 Sep 15;82(6):1820-8
8104532
Blood. 2010 Jun 3;115(22):4393-402
20194898
Br J Haematol. 2011 Feb;152(3):295-306
21155758
Blood. 2013 Oct 24;122(17):3010-9
24014238
Leukemia. 2015 Aug;29(8):1702-12
25882699
Leuk Res. 2016 Jul;46:30-6
27111859
N Engl J Med. 2013 Jul 4;369(1):32-42
23782158
Leukemia. 2017 Oct;31(10):2075-2084
28111464
Immunol Lett. 2013 Sep-Oct;155(1-2):36-9
24095849
Leukemia. 2000 Jan;14(1):40-6
10637475
Leukemia. 2014 Jun;28(6):1207-15
24402163
Blood. 2014 Jun 26;123(26):4111-9
24786774
Br J Haematol. 2013 Oct;163(1):139-42
23826785
Cell Death Dis. 2015 Jan 15;6:e1593
25590803
N Engl J Med. 2014 Jul 17;371(3):213-23
24881631
Blood. 2014 Oct 2;124(14):2196-202
25143487
J Clin Oncol. 2009 Dec 10;27(35):6012-8
19826119
Clin Cancer Res. 2015 Aug 15;21(16):3705-15
25829398
Drugs. 2015 May;75(7):769-76
25802231
Br J Haematol. 2015 Sep;170(5):669-78
25942994
Leuk Lymphoma. 2015;56(12):3250-6
26062943
Blood. 2015 Mar 26;125(13):2062-7
25573991
JAMA Oncol. 2015 Apr;1(1):80-7
26182309
Lancet Oncol. 2015 Feb;16(2):169-76
25555420
Br J Haematol. 2001 May;113(2):383-90
11380403
PLoS One. 2012;7(6):e38158
22675518
Pharmacol Res Perspect. 2015 Oct;3(5):e00178
26516589
N Engl J Med. 2014 Mar 13;370(11):997-1007
24450857
Leuk Res. 2015 May;39(5):495-500
25804339
Leuk Lymphoma. 2015;56(10):2826-33
25797560
Sci Transl Med. 2015 Mar 18;7(279):279ra40
25787766
Mol Cancer Ther. 2013 Sep;12(9):1691-700
23974697
Blood. 2014 May 29;123(22):3390-7
24615777
J Clin Oncol. 2012 Feb 10;30(5):488-96
22184378
Blood. 2015 Apr 16;125(16):2497-506
25700432
J Clin Oncol. 2009 Nov 1;27(31):5208-12
19738118
Leukemia. 2015 Jul;29(7):1602-4
25634683
J Clin Oncol. 2011 Sep 10;29(26):3559-66
21844497
Nat Rev Drug Discov. 2008 Dec;7(12):989-1000
19043450
N Engl J Med. 2014 Jun 12;370(24):2286-94
24869598
Leuk Lymphoma. 2013 Aug;54(8):1823-5
23614795
Br J Pharmacol. 2016 Feb;173(3):471-83
26493374
Blood. 2012 Oct 25;120(17):3501-9
22955911